Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline

L C Silbert1, C Nelson, D B Howieson

  • 1Layton Aging and Alzheimer's Disease Center, Department of Neurology, CR-131, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97201, USA. silbertl@ohsu.edu

Neurology
|July 9, 2008
PubMed
Abstract

Insights

White matter hyperintensity (WMH) progression impacts gait and memory in older adults. This study shows increased WMH burden is linked to higher risks of cognitive and motor decline, not a benign aging process.

Area of Science:

  • Neuroimaging
  • Geriatric Medicine
  • Neurology

Background:

  • White matter hyperintensity (WMH) is common in the elderly and linked to cognitive decline.
  • Understanding WMH progression's impact on brain structure and function is crucial for aging syndromes and dementia risk.

Purpose of the Study:

  • To investigate the relationship between white matter hyperintensity (WMH) volume, its progression, and changes in brain structure, cognition, and motor function over time.
  • To assess the risk associated with WMH progression in cognitively intact elderly individuals.

Main Methods:

  • Longitudinal study of 104 cognitively intact older adults over 13 years with at least three MRI scans.
  • Annual cognitive and neurologic assessments alongside brain volume, ventricular CSF (vCSF), and periventricular (PV) and subcortical WMH volume measurements.
  • Analysis of MRI volume progression in relation to cognitive, motor, and cerebral volume change rates.

Main Results:

  • Higher initial total and PV WMH volume correlated with increased WMH, vCSF progression, and slower gait.
  • PV WMH volume progression was linked to slower walking times.
  • Subcortical WMH volume progression associated with memory decline and increased vCSF volume.

Conclusions:

  • Increased total and PV WMH burden, and PV WMH progression, are linked to poorer gait performance.
  • Subcortical WMH volume progression is associated with memory decline in the cognitively intact elderly.
  • WMH progression increases the risk of memory and gait dysfunction, indicating it is not a benign aging process.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...